A new large-scale manufacturing platform for complex biopharmaceuticals.
about
Membrane adsorbers comprising grafted glycopolymers for targeted lectin binding.Continuous downstream processing for high value biological products: A Review.Principles and approach to developing mammalian cell culture media for high cell density perfusion process leveraging established fed-batch media.BAY 81-8973, a full-length recombinant factor VIII: manufacturing processes and product characteristics.Bioreactor productivity and media cost comparison for different intensified cell culture processes.Continuous counter-current chromatography for capture and polishing steps in biopharmaceutical production.Scale-Up of Protein Purification: Downstream Processing Issues.Silk screen based dual spin-filter module for perfusion culture of adherent and non-adherent mammalian cells.Continuous Manufacturing of Recombinant Therapeutic Proteins: Upstream and Downstream Technologies.Zonal rate model for axial and radial flow membrane chromatography. Part I: knowledge transfer across operating conditions and scales.Scale-up of affinity membrane modules: comparison between lumped and physical models.Zonal rate model for axial and radial flow membrane chromatography, part II: model-based scale-up.Development of a 3-step straight-through purification strategy combining membrane adsorbers and resins.Trends in Upstream and Downstream Process Development for Antibody Manufacturing.A tandem laboratory scale protein purification process using Protein A affinity and anion exchange chromatography operated in a weak partitioning mode.Continuous precipitation of IgG from CHO cell culture supernatant in a tubular reactor.Factors that determine stability of highly concentrated chemically defined production media.
P2860
Q35292040-E56B01AD-8683-4D7A-818F-0237AC4FA9F9Q38543755-970AA288-854B-4975-A411-7A7AFDB1ECD6Q38709169-72F34BAB-4C24-4D5E-B7FE-A69421C034B0Q38725317-E2ECAF58-42AD-43FF-B1FE-B9EF64AD296FQ38726126-A31B0698-CA9F-4AF8-BEC1-A3FD10583318Q38845449-AA15C1D2-BE8E-4BBA-A2C0-539278BC2780Q38978537-10A6BA72-1D6E-43F8-B023-8CBCAF6F680FQ39003694-1D25494C-17A5-473E-802D-B222D21E7933Q39164854-B6A3968E-FC28-43CB-B395-7F382D3F46D4Q41250249-D1644FE0-37ED-4A88-8A66-F76710D0CF88Q41462450-599C5B89-CE76-4CA5-9D3C-EFE0C18B6F00Q46754434-B192CEC4-FFE7-4147-8201-B3C36A9A4CFFQ47361669-CE8D0B52-362C-4373-AC11-1929DD7BB257Q47843398-6E3A9C56-1FF0-47CD-9563-C368A6FDCC95Q51028167-FE11E6DE-C214-4D6F-9B55-3D593916D94DQ51744054-083C3DF3-4F7B-44E4-B652-D7858480F541Q51744750-60F5F648-D02A-46E3-A76C-59658B4C81D3
P2860
A new large-scale manufacturing platform for complex biopharmaceuticals.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
A new large-scale manufacturing platform for complex biopharmaceuticals.
@en
A new large-scale manufacturing platform for complex biopharmaceuticals.
@nl
type
label
A new large-scale manufacturing platform for complex biopharmaceuticals.
@en
A new large-scale manufacturing platform for complex biopharmaceuticals.
@nl
prefLabel
A new large-scale manufacturing platform for complex biopharmaceuticals.
@en
A new large-scale manufacturing platform for complex biopharmaceuticals.
@nl
P2093
P2860
P356
P1476
A new large-scale manufacturing platform for complex biopharmaceuticals.
@en
P2093
Anil Salgotra
Huong Nguyen
Jennifer Tom
Jens H Vogel
Jolene Ignowski
Roberto Giovannini
Steve Garger
P2860
P304
P356
10.1002/BIT.24578
P577
2012-06-20T00:00:00Z